SIRT4 Has an Anti-Cancer Role in Cervical Cancer by Inhibiting Glutamine Metabolism via the MEK/ERK/C-Myc Axis
Anticancer Research · 2024
DOI: 10.21873/anticanres.17098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Yina Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Women's Hospital, School of Medicine, Zhejiang University, Zhejiang, P.R. China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Glutamine, Sirtuins, Cell Proliferation. Die Arbeit wurde bisher 10-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Women's Hospital, School of Medicine, Zhejiang University, Zhejiang, P.R. China.
- Women's Hospital, School of Medicine, Zhejiang University, Zhejiang, P.R. China 5511012@zju.edu.cn.
Zitieren
APA
Zhang, Y., Niu, X., Wang, Y., Bao, S., Jiang, P., & Dong, X. (2024). SIRT4 Has an Anti-Cancer Role in Cervical Cancer by Inhibiting Glutamine Metabolism via the MEK/ERK/C-Myc Axis. Anticancer Research. https://doi.org/10.21873/anticanres.17098
Vancouver
Zhang Y, Niu X, Wang Y, Bao S, Jiang P, Dong X. SIRT4 Has an Anti-Cancer Role in Cervical Cancer by Inhibiting Glutamine Metabolism via the MEK/ERK/C-Myc Axis. Anticancer Research. 2024. doi:10.21873/anticanres.17098
BibTeX
@article{Zhang2024,
author = {Zhang, Yina and Niu, Xiaocen and Wang, Yuanhe and Bao, Shuting and Jiang, Peiyue and Dong, Xiaorui},
title = {SIRT4 Has an Anti-Cancer Role in Cervical Cancer by Inhibiting Glutamine Metabolism via the MEK/ERK/C-Myc Axis},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.17098}
}
EUVIMED